According to the Economic Times, the Indian Pharmaceutical market will grow to $20 billion by the year 2015. This is up radically from $7.1 billion in 2007. Many factors account for the increase of the standards and rules put in place to protect the patients, including patent examiners, decentralization of the filing process and digitization of records. In addition, due to the growing middle class, many more citizens are expected to be able to afford high value medication.
Read the full article here.
About:
The Partnerships in Clinical Trials Blog focuses optimization intelligence, regulatory trends and globalization strategies for both as sponsors and CROs. It is an extension of the Partnerships in Clinical Trials Conference.
As a reader of the Partnerships in Clinical Trials blog, mention code XP1718BLOG when registering to join us in Sao Paulo for Partnerships in Clinical Trials Latin America to receive a discount of $100 off the current rate!
Would you like to guest blog on our site? Or send us feedback? Send an email to jpereira@iirusa.com.



.gif)
0 comments:
Post a Comment